Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?

E-ISSN： 1478-3231|35|7|1862-1871

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.7, 2015-07, pp. : 1862-1871

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What can we learn from ‘dropouts’ in clinical trials?

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : 318-319

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeted Therapies and Survival: What We Can Learn from Studies in Advanced Renal Cell Carcinoma

Oncology, Vol. 84, Iss. 1, 2012-10 ,pp. : 39-42

Karger

Access to resources Recommend Favorite

B‐type natriuretic peptide and heart failure: what can we learn from clinical trials?

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 42, Iss. 9, 2015-09 ,pp. : 881-887

John Wiley & Sons Inc

Access to resources Recommend Favorite

What can we learn from international comparisons of costs by DRG?

By Pirson M. Schenker L. Martins D. Dung Duong Chalé J. Leclercq P.

The European Journal of Health Economics, Vol. 14, Iss. 1, 2013-02 ,pp. : 67-73

Springer Publishing Company

Access to resources Recommend Favorite

Pressure to Lead: What Can We Learn from the Theory?

By Stewart Lisa S P

The British Journal of Occupational Therapy, Vol. 70, Iss. 6, 2007-06 ,pp. : 228-234

College of Occupational Therapists

Access to resources Recommend Favorite